Exploring quality of life and satisfaction with treatment in asthmatic patients receiving dry powder inhalers: a multinational survey

Abstract

Introduction: The quality of life (QoL) and device needs have not been characterized in asthmatic patients treated via dry powder inhalers (DPIs). The aim of this study was to assess the impact of asthma on health-related QoL, device satisfaction, and preference in adult asthmatic patients using DPI devices, and to identify any DPI-associated unmet needs. Methods: An online survey was conducted between November and December 2019 on eligible patients from the Cint consumer panel across Europe. Newly designed, as well as validated questionnaires were used to collect data on QoL and inhaler satisfaction. Results: A total of 1063 asthmatic patient took part in the survey; 66% of the patients reported medium or high impact of asthma on the overall QoL. The majority of patients (61%) reported high level of satisfaction with their current device. The patients with medium-to-high impact of asthma on QoL were significantly less likely to be satisfied with their current device (55%) than those who reported low-to-medium impact of asthma on QoL (67%; p-value < 0.001). "Higher number of available doses, " "usability, " "clear dose counter, " and "feedback on correct inhalation" were the attributes mostly requested from a new device. The demand for user-friendly devices that provide feedback on correct drug administration was identified as an unmet need. Conclusions and clinical relevance:In asthmatic patients with medium to high impact of asthma on the overall QoL, the satisfaction with the device is highly affected.

Postrzeganie inhalatorów suchego proszku przez chorych na astmę

“…Ciekawe rezultaty przyniosło badanie Contolego i wsp. dotyczące DPI opublikowane w 2022 r. i przeprowadzone wśród 1063 chorych na astmę w siedmiu krajach europejskich [31]. Respondentów poproszono o wybranie dwóch najważniejszych i dwóch najmniej istotnych atrybutów DPI.…”